While studies of SOD1 levels in CSF have produced conflicting results, CSF levels of NfL—but not TDP-43—have consistently demonstrated utility in differentiating ALS from mimics such as Guillain–Barre syndrome [117,118]. Here, SOD1 is linked to amyotrophic lateral sclerosis.